TP53 and neoplasm: To address the above-mentioned flaws and limitations, future studies should aim to reduce dropout rates, characterize the genetic background of participants, analyze p53 levels in tumor samples, and explore additional molecular pathways that may contribute to the cancer-stabilizing effects of Nutri-PEITC Jelly.